OptimizeRx Corporation (OPRX)
NASDAQ: OPRX · Real-Time Price · USD
5.11
-0.27 (-5.02%)
At close: Jun 5, 2026, 4:00 PM EDT
5.05
-0.06 (-1.10%)
After-hours: Jun 5, 2026, 7:59 PM EDT

OptimizeRx Stock Forecast

Stock Price Forecast

According to 7 analysts polled by S&P Global, OptimizeRx stock has a consensus rating of "Strong Buy" and an average price target of $11.5. The average 1-year stock price forecast is 125.05% higher than the current stock price, while the lowest is $7.00 (+36.99%) and the highest is $18 (+252.25%).

Price Target: $11.5 (+125.05%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$7.00$11.5$10.5$18
Change+36.99%+125.05%+105.48%+252.25%

Analyst Ratings

The average analyst rating for OptimizeRx stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingAug '25Oct '25Nov '25Mar '26Apr '26May '26
Strong Buy555555
Buy111111
Hold111111
Sell000000
Strong Sell000000
Total777777

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
B. Riley Securities
B. Riley Securities
Buy
Maintains
$11$10
BuyMaintains$11$10+95.69%May 13, 2026
Stephens
Stephens
Hold
Reiterates
$7
HoldReiterates$7+36.99%May 13, 2026
Stifel Nicolaus
Stifel Nicolaus
Buy
Reiterates
$17$14
BuyReiterates$17$14+173.97%May 13, 2026
William Blair
William Blair
Buy
Reiterates
n/a
BuyReiteratesn/an/aMay 13, 2026
Roth MKM
Roth MKM
Buy
Reiterates
$18
BuyReiterates$18+252.25%May 13, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
97.44M
from 109.43M
Decreased by -10.96%
Revenue Next Year
108.40M
from 97.44M
Increased by 11.25%
EPS This Year
0.92
from 1.05
Decreased by -12.70%
EPS Next Year
1.06
from 0.92
Increased by 15.27%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
61.29M62.45M71.52M92.13M109.43M97.44M
Revenue Growth
41.51%1.89%14.53%28.81%18.78%-10.96%
Gross Profit
35.64M38.97M42.90M59.38M73.60M66.95M
Gross Margin
58.14%62.40%59.98%64.45%67.25%68.71%
Operating Income
361.10K-12.29M-13.25M-5.97M12.06M10.26M
Net Income
378.08K-11.44M-17.57M-20.11M5.13M4.97M
EPS
----1.050.92
EPS Growth
----218.18%-12.70%
Forward PE
106.1239.8447.1818.0717.375.57
Free Cash Flow
-1.40M14.86M-2.32M9.31M16.27M6.10M
No. Analysts
-----7
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High98.6M
Avg97.4M
Low95.0M

Revenue Growth

Revenue Growth202620272028
High
-9.9%
Avg
-11.0%
Low
-13.2%

EPS Forecast

EPS202620272028
High1.00
Avg0.92
Low0.81

EPS Growth

EPS Growth202620272028
High
-4.8%
Avg
-12.7%
Low
-22.9%